Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Long-Term Obeticholic Acid (OCA) treatment associated with reversal or stabilization of fibrosis/cirrhosis in patients with Primary Biliary Cholangitis (PBC) (2018) Bowlus C, Pockros P, Kremer A, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution Pruritus strongly reduces quality of life in PBC patients - real life data from a large national survey (2018) Hönig S, Herder B, Kautz A, Trautwein C, Kremer A Conference contribution Lysophosphatidic acid activates peripheral glia cells via LPA receptor 1 (2018) Wolf K, Gebhardt L, Robering J, Fischer M, Kremer A Conference contribution Functional connectivity reveals altered activation of distinct brain areas in pruritus of cholestasis (2018) Kremer A, Buchwald T, Vetter M, Dörfler A, Forster C Conference contribution Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study (2018) Schalk P, Kohl M, Herrmann HJ, Schwappacher R, Rimmele M, Büttner A, Neurath M, et al. Journal article Microbiome and gut immunity: The epithelium (2018) Günther C Book chapter / Article in edited volumes The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target (2018) Wei J, Marangoni RG, Fang F, Wang W, Huang J, Distler J, Varga J Journal article Effects of low-volume high-intensity interval training in a community setting: a pilot study (2018) Reljic D, Wittmann F, Fischer JE Journal article Effects of time-efficient, high intensity Interval Endurance Training on cardiorespiratory Fitness and cardiometabolic Risk Markers in a Real-World-Setting: A randomized-controlled Pilot Study (2018) Reljic D, Wittmann F, Fischer J Conference contribution